Ligand validation:3SRA

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 3SRA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SRA_MYR_B_763	29%	67%	0.197	0.857	0.25	0.99	-	-	4	0	100%	0.9375
3L94_MYR_B_800	26%	67%	0.184	0.824	0.43	0.82	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
7OWU_MYR_C_101	84%	69%	0.106	0.967	0.53	0.66	-	-	1	0	100%	0.9375
5O9U_MYR_C_101	81%	64%	0.111	0.964	0.58	0.8	-	-	0	0	100%	0.9375
4L8U_MYR_A_602	77%	60%	0.116	0.957	0.58	0.95	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.